BlackRock Capital Allocation Term Trust
corporate_fare Company Profile
BlackRock Capital Allocation Term Trust (NYSE:BCAT) is a publicly traded company in the Finance sector. Wiseek has independently scored 2 items for BCAT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-10, rated 7/10. Across its 2 most recent items scored 7 or higher, the top rating is 7/10. Recent SEC coverage for BCAT spans 497AD.
Recent high-impact activity:
- BCAT Rights Offering: 5 Rights Buy 1 Share at Up to 1.5% Discount to NAV
- BCAT Launches Transferable Rights Offering at Up to 1.5% Discount to NAV
Short Interest & Short Volume
2.08 days to coverFINRA reported short interest of 2,523,119 shares in BCAT as of the September 15, 2026 settlement, a 84.2% increase from the prior period — about 2.1 days to cover at its recent average daily volume. On October 2, 2026, 42.3% of BCAT volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for BCAT, detected from its recent SEC filings · based on capital-structure filings through 2026-06-12.
Shelf Registration Filed · Potential Dilution
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →